ASHLEY RABURN: Open Payments
NPI 1477995645 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,449 in 62 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $655 · 2025 $1,449
Food & beverage: $1,397Education: $52
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $321 |
| Regeneron Healthcare Solutions, Inc. | 9 | $220 |
| GENZYME CORPORATION | 9 | $205 |
| Organon LLC | 2 | $150 |
| GlaxoSmithKline, LLC. | 5 | $119 |
| AstraZeneca Pharmaceuticals LP | 6 | $107 |
| PFIZER INC. | 2 | $58 |
| BioCryst US Sales Co., LLC | 2 | $55 |
| Optinose US, Inc. | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
Products named: DUPIXENT, Rhapsido, VTAMA, NUCALA, XHANCE, FASENRA, ORLADEYO, TEZSPIRE.
Industry payments across LA — which companies pay providers there.
